Novel heterocycle derivatives useful as selective androgen receptor modulators (SARMs)

Details for Australian Patent Application No. 2005307003 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Li, Xiaojie; Sui, Zhihua; Zhang, Xuqing

Agent Shelston IP

Pub. Number AU-B-2005307003

PCT Pub. Number WO2006/055184

Priority 60/628,337 16.11.04 US

Filing date 25 October 2005

Wipo publication date 26 May 2006

Acceptance publication date 13 October 2011

International Classifications

C07D 231/04 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 261/04 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 263/04 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 263/08 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/055184 Priority application(s): WO2006/055184

13 October 2011 Application Accepted

  Published as AU-B-2005307003

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005307005-Spinal prosthesis having a modular design

2005306997-Anti-ADDL antibodies and uses thereof